Literature DB >> 18432904

Peptide induction of surface expression of class I MHC.

Ted Hansen1, Nancy Myers.   

Abstract

This unit describes a method for comparing the relative binding of different peptides to the same MHC class I (MHC-I) molecule using live cells. Live cells expressing suboptimally loaded MHC-I proteins are incubated with medium containing diluted amounts of synthetic peptides to be tested for binding to class I. After overnight incubation with peptide, surface class I expression is monitored by flow cytometry using an allele-specific MAb. Relative binding affinity of peptide reliably correlates with the amount of surface induction of the class I molecule to which it specifically binds. The mechanistic basis of this assay is that surface MHC-I molecules become conformationally unstable shortly after peptide dissociation. However, the binding of an exogenous peptide can stabilize the surface class I molecule, prevent conformational instability, and thus increase class I surface expression in an allele-specific manner.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 18432904     DOI: 10.1002/0471142735.im1811s57

Source DB:  PubMed          Journal:  Curr Protoc Immunol        ISSN: 1934-3671


  3 in total

1.  Breast Cancer Neoantigens Can Induce CD8+ T-Cell Responses and Antitumor Immunity.

Authors:  Xiuli Zhang; Samuel Kim; Jasreet Hundal; John M Herndon; Shunqiang Li; Allegra A Petti; Savas D Soysal; Lijin Li; Mike D McLellan; Jeremy Hoog; Tina Primeau; Nancy Myers; Tammi L Vickery; Mark Sturmoski; Ian S Hagemann; Chris A Miller; Matthew J Ellis; Elaine R Mardis; Ted Hansen; Timothy P Fleming; S Peter Goedegebuure; William E Gillanders
Journal:  Cancer Immunol Res       Date:  2017-06-15       Impact factor: 11.151

2.  The cellular environment regulates in situ kinetics of T-cell receptor interaction with peptide major histocompatibility complex.

Authors:  Baoyu Liu; Wei Chen; Kannan Natarajan; Zhenhai Li; David H Margulies; Cheng Zhu
Journal:  Eur J Immunol       Date:  2015-05-22       Impact factor: 5.532

3.  Proteogenomic Analysis Unveils the HLA Class I-Presented Immunopeptidome in Melanoma and EGFR-Mutant Lung Adenocarcinoma.

Authors:  Yue A Qi; Tapan K Maity; Constance M Cultraro; Vikram Misra; Xu Zhang; Catherine Ade; Shaojian Gao; David Milewski; Khoa D Nguyen; Mohammad H Ebrahimabadi; Ken-Ichi Hanada; Javed Khan; Cenk Sahinalp; James C Yang; Udayan Guha
Journal:  Mol Cell Proteomics       Date:  2021-08-13       Impact factor: 5.911

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.